Page last updated: 2024-08-21

medroxyprogesterone and Neoplasms

medroxyprogesterone has been researched along with Neoplasms in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-199038 (82.61)18.7374
1990's1 (2.17)18.2507
2000's4 (8.70)29.6817
2010's3 (6.52)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, GL; Aragaki, AK; Chlebowski, RT; Espeland, MA; Howard, BV; Jackson, RD; Johnson, KC; LaCroix, AZ; Lewis, CE; Manson, JE; Margolis, KL; Martin, LW; Prentice, RL; Rossouw, JE; Shumaker, SA; Stefanick, ML; Thomson, CA; Wactawski-Wende, J1
Contu, P; Dessì, M; Macciò, A; Madeddu, C; Mantovani, G; Massa, E; Panzone, F; Serpe, R1
Mantovani, G1
BLOOM, HJ; DUKES, CE; MITCHLEY, BC1
BAKER, WH; BLOOM, HJ; DUKES, CE; MITCHLEY, BC1
ARPELS, C; BABCOCK, VI; SOUTHAM, CM1
CRAIG, JM; KISTNER, RW; STEINER, GJ1
ANDERSON, DG1
PELNER, L; RHOADES, MG1
Astara, G; Deiana, L; Gramignano, G; Lusso, MR; Macciò, A; Madeddu, C; Mantovani, G; Massa, E; Serpe, R1
Amato, G; Capuano, F; Carella, C; Figlia, A; Papaleo, C; Zito, GA1
Pawlicki, M; Zuchowska-Vogelgesang, B1
Battaglia, A; Bernardo, G; Brunner, K; Cavalli, F; Ganzina, F; Goldhirsch, A; Isetta, AM; Robustelli della Cuna, G; Sacchetti, G; Tamassia, V1
Camaggi, CM; Canova, N; Giovannini, M; Murari, G; Pannuti, F; Strocchi, E1
Angelelli, B; Camaggi, CM; Costanti, B; Ferrari, P; Giovannini, M; Pannuti, F; Strocchi, E; Zebini, E1
Angelelli, B; Camaggi, CM; Colalongo, F; Costanti, B; Giambiasi, ME; Lelli, G; Pannuti, F; Strocchi, E1
DeStefano, F; Guidotti, R; Jones, V; Layde, PM; Levenson, AG; Michelson, M; Ory, HW; Peterson, H; Rubin, GL; Wingo, P1
Ordelman, GJ1
Priestman, TJ1
Revaz, C1
Angelelli, B; Lelli, G; Mondini, F; Monetti, N; Pannuti, F; Piana, E; Strocchi, E; Zanichelli, L1
Oldenkamp, EP; van Laar, PH; van Os, JL; Verschoor, JS1
Minkin, S1
Fraser, IS; Weisberg, E1
Benagiano, G; Fraser, I1
Blomster, M1
Camaggi, CM; Costanti, B; Di Marco, AR; Giovannini, M; Pannuti, F; Strocchi, E1
Dragosky, M; Gustavo Gercovich, F; Martínez, RE; Morgenfeld, E; Murro, H; Presman, A; Sorrentino, M1
Barnes, DM; Hayden, DW; Johnson, KH; Johnston, SD; Kiang, DT1
Furberg, C; Grady, D; Herrington, D; Hulley, S; Hunninghake, D; Khan, S; Vittinghoff, E; Wenger, NK1
Bachmann, P; Béal, J; Benamouzig, R; Blanc-Vincent, MP; Colomb, V; Desport, JC; Gory-Delabaere, G; Kere, D; Melchior, JC; Nitenberg, G; Raynard, B; Scheiner, S; Senesse, P1
Coleman, ME; Feenstra, ES; Frank, DW; Gilbertson, TJ; Kimball, FA; Kirton, KT; Murchison, TE; Quinlan, WJ1
Mohberg, NR; Schwallie, PC1
Geyer, G; Lang, I; Spona, J; Templ, H; Zielinski, CC1
Keller, PJ1
Camaggi, CM; Pannuti, F; Strocchi, E1
Beghelli, P; Camaggi, CM; Costanti, B; Ferrari, P; Pannuti, F; Strocchi, E1
Lusk, W; Sadoff, L1
Gaudin, D; Guthrie, L; Yielding, KL1
Cali, RW1
Mann, CJ1

Reviews

5 review(s) available for medroxyprogesterone and Neoplasms

ArticleYear
[New antineoplastic agents, their value and use].
    Przeglad lekarski, 1982, Volume: 39, Issue:8

    Topics: Aminacrine; Antineoplastic Agents; Aspartic Acid; Cisplatin; Etoposide; Humans; Ifosfamide; Interferons; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Neoplasms; Phosphonoacetic Acid; Razoxane; Tamoxifen; Teniposide; Vinca Alkaloids

1982
A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
    The Medical journal of Australia, 1981, 01-24, Volume: 1, Issue:SP1

    Topics: Australia; Blood Pressure; Breast Neoplasms; Contraceptives, Oral; Drug Implants; Female; Fertility; Fetus; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Thrombophlebitis; Uterine Cervical Neoplasms

1981
The Depo-Provera debate. Commentary on the article "Depo-Provera, a critical analysis".
    Contraception, 1981, Volume: 24, Issue:5

    Topics: Animals; Breast Feeding; Carbohydrate Metabolism; Carcinogens; Delayed-Action Preparations; Dogs; Endometrium; Family Planning Services; Female; Haplorhini; Humans; Immunosuppression Therapy; Infant, Newborn; Liver; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Neoplasms; Pregnancy; Risk; United States; United States Food and Drug Administration

1981
[Hormonal contraception using depot preparations].
    Therapeutische Umschau. Revue therapeutique, 1986, Volume: 43, Issue:5

    Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk

1986
Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting.
    Bulletin of the World Health Organization, 1986, Volume: 64, Issue:3

    Topics: Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Risk

1986

Trials

6 trial(s) available for medroxyprogesterone and Neoplasms

ArticleYear
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
    JAMA, 2017, 09-12, Volume: 318, Issue:10

    Topics: Aged; Cardiovascular Diseases; Cause of Death; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Mortality; Neoplasms; Postmenopause; Risk

2017
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.
    The oncologist, 2010, Volume: 15, Issue:2

    Topics: Appetite Stimulants; Cachexia; Carnitine; Eicosapentaenoic Acid; Female; Humans; Interleukin-6; Male; Medroxyprogesterone; Megestrol Acetate; Middle Aged; Neoplasms; Thalidomide; Vitamin B Complex

2010
Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
    European review for medical and pharmacological sciences, 2010, Volume: 14, Issue:4

    Topics: Aged; Body Composition; Cachexia; Carnitine; Contraceptives, Oral, Hormonal; Eicosapentaenoic Acid; Endpoint Determination; Energy Metabolism; Female; Humans; Male; Medroxyprogesterone; Megestrol; Middle Aged; Motor Activity; Neoplasms; Prognosis; Thalidomide

2010
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2006, Volume: 15, Issue:5

    Topics: Adult; Aged; Anorexia; Ascorbic Acid; Cachexia; Carbocysteine; Celecoxib; Dietary Supplements; Docosahexaenoic Acids; Female; Humans; Linear Models; Male; Medroxyprogesterone; Middle Aged; Neoplasms; Nutritional Support; Oxidative Stress; Pyrazoles; Statistics, Nonparametric; Sulfonamides; Thioctic Acid; Treatment Outcome; Vitamin A; Vitamin E

2006
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
    Annals of internal medicine, 2000, May-02, Volume: 132, Issue:9

    Topics: Aged; Coronary Disease; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Hospitalization; Humans; Leg Injuries; Medroxyprogesterone; Multivariate Analysis; Neoplasms; Proportional Hazards Models; Pulmonary Embolism; Risk Factors; Surgical Procedures, Operative; Venous Thrombosis

2000
Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Leukopenia; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Random Allocation; Rectal Neoplasms; Thrombocytopenia; Time Factors

1986

Other Studies

35 other study(ies) available for medroxyprogesterone and Neoplasms

ArticleYear
HORMONE-DEPENDENT TUMOURS OF THE KIDNEY. I. THE OESTROGEN-INDUCED RENAL TUMOUR OF THE SYRIAN HAMSTER. HORMONE TREATMENT AND POSSIBLE RELATIONSHIP TO CARCINOMA OF THE KIDNEY IN MAN.
    British journal of cancer, 1963, Volume: 17

    Topics: Adenocarcinoma; Animals; Carcinoma; Cortisone; Cricetinae; Diethylstilbestrol; Estrogens; Kidney Neoplasms; Medroxyprogesterone; Mesocricetus; Neoplasms; Neoplasms, Experimental; Pathology; Physiology; Research; Testosterone; Toxicology

1963
HORMONE-DEPENDENT TUMOURS OF THE KIDNEY. II. EFFECT OF ENDOCRINE ABLATION PROCEDURES ON THE TRANSPLANTED OESTROGEN-INDUCED RENAL TUMOUR OF THE SYRIAN HAMSTER.
    British journal of cancer, 1963, Volume: 17

    Topics: Adrenalectomy; Animals; Castration; Cricetinae; Diethylstilbestrol; Estradiol; Estrogens; Humans; Kidney; Kidney Neoplasms; Male; Medroxyprogesterone; Mesocricetus; Neoplasms; Neoplasms, Experimental; Orchiectomy; Pharmacology; Research; Testis; Testosterone; Toxicology

1963
EFFECT OF STEROIDS ON HUMAN CELL CULTURES; SUSTAINING EFFECT OF HYDROCORTISONE.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1964, Volume: 115

    Topics: 17-Ketosteroids; Androsterone; Dehydroepiandrosterone; Estradiol; Etiocholanolone; Hydrocortisone; Hydroxyprogesterones; Medroxyprogesterone; Neoplasms; Pharmacology; Progestins; Research; Steroids; Testosterone; Tissue Culture Techniques

1964
HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
    Metabolism: clinical and experimental, 1963, Volume: 14

    Topics: Carcinoma in Situ; Drug Therapy; Endometrial Hyperplasia; Endometrium; Female; Geriatrics; Humans; Hydroxyprogesterones; Hyperplasia; Hysterectomy; Medroxyprogesterone; Menopause; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Pathology; Progestins; Uterine Neoplasms

1963
MANAGEMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA WITH MEDROXYPROGESTERONE ACETATE.
    American journal of obstetrics and gynecology, 1965, May-01, Volume: 92

    Topics: Adenocarcinoma; Disease Management; Female; Geriatrics; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Palliative Care; Uterine Neoplasms

1965
HOST-TUMOR ANTAGONISM. 34. THE USE OF PROGESTATIONAL AGENTS TO RETARD HOMOGRAFT REJECTION IN RABBITS; A PILOT STUDY.
    Journal of the American Geriatrics Society, 1965, Volume: 13

    Topics: Allografts; Animals; Female; Hydroxyprogesterones; Immune Tolerance; Immunosuppressive Agents; Medroxyprogesterone; Neoplasms; Pharmacology; Pilot Projects; Pregnancy; Pregnancy, Animal; Progestins; Rabbits; Research; Skin Transplantation; Transplantation Immunology; Transplantation, Homologous

1965
ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:4

    Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Uterine Neoplasms

1984
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology.
    Cancer chemotherapy and pharmacology, 1982, Volume: 8, Issue:2

    Topics: Biological Availability; Breast Neoplasms; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Time Factors

1982
Medroxyprogesterone acetate (MAP) plasma levels after simultaneous oral and intramuscular administration in cancer patients.
    Cancer chemotherapy and pharmacology, 1982, Volume: 9, Issue:2

    Topics: Administration, Oral; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms

1982
Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients.
    Cancer chemotherapy and pharmacology, 1983, Volume: 11, Issue:1

    Topics: Administration, Oral; Antineoplastic Agents; Biological Availability; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms

1983
The anabolic effect of high dose medroxyprogesterone acetate in oncology.
    Pharmacological research communications, 1983, Volume: 15, Issue:6

    Topics: Anabolic Agents; Anorexia; Hemodynamics; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Nitrogen; Pain; Psychomotor Performance

1983
Mortality among young black women using contraceptives.
    JAMA, 1984, Feb-24, Volume: 251, Issue:8

    Topics: Adolescent; Adult; Black or African American; Contraception; Contraceptives, Oral; Family Planning Services; Female; Georgia; Humans; Intrauterine Devices; Medroxyprogesterone; Medroxyprogesterone Acetate; Mortality; Neoplasms; Parity; Risk; Vaginal Creams, Foams, and Jellies

1984
[The occurrence of mammary tumors in bitches following treatment with Delvosteron injection or Perlutex injection for the prevention of estrus, compared to 2 control groups].
    Tijdschrift voor diergeneeskunde, 1984, Feb-15, Volume: 109, Issue:4

    Topics: Animals; Dog Diseases; Dogs; Female; Mammary Glands, Animal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Progesterone; Progesterone Congeners

1984
Quality of life after cytotoxic chemotherapy: discussion paper.
    Journal of the Royal Society of Medicine, 1984, Volume: 77, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Quality of Life; Self-Assessment; Surveys and Questionnaires

1984
[Real and false risks of injectable hormonal contraception].
    Gynakologische Rundschau, 1984, Volume: 24 Suppl 1

    Topics: Abnormalities, Drug-Induced; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Infant, Newborn; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Pregnancy; Risk

1984
The effect of high dose medroxyprogesterone acetate on water and salt metabolism in advanced cancer patients.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:5

    Topics: Antineoplastic Agents; Body Water; Electrolytes; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Water-Electrolyte Balance

1984
Oestrus control and the incidence of mammary nodules in bitches, a clinical study with two progestogens.
    The veterinary quarterly, 1981, Volume: 3, Issue:1

    Topics: Animals; Contraception; Dog Diseases; Dogs; Female; Mammary Glands, Animal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Progesterone; Progesterone Congeners

1981
Depo-Provera: a critical analysis.
    Women & health, 1980,Summer, Volume: 5, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Breast Feeding; Contraceptive Agents, Female; Dogs; Female; Haplorhini; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Neoplasms; Pregnancy; United States; United States Food and Drug Administration; Uterine Neoplasms

1980
Injectable hormonal contraceptives: technical and safety aspects.
    WHO offset publication, 1982, Issue:65

    Topics: Adolescent; Adult; Animals; Contraceptive Agents, Female; Dogs; Drug Labeling; Family Planning Services; Female; Fertility; Haplorhini; Humans; Injections, Intramuscular; Medroxyprogesterone; Menstruation Disturbances; Neoplasms; Norethindrone; Rats

1982
[Monica was reported when she refused to give Depo-Provera. Interview by Susanne Gäre].
    Vardfacket, 1982, Apr-08, Volume: 6, Issue:7

    Topics: Contraceptives, Oral; Contraceptives, Oral, Synthetic; Humans; In Vitro Techniques; Medroxyprogesterone; Neoplasms

1982
Medroxyprogesterone acetate (MAP) relative bioavailability after single high-dose administration in cancer patients.
    Cancer treatment reports, 1982, Volume: 66, Issue:12

    Topics: Administration, Oral; Biological Availability; Chromatography, Gas; Dose-Response Relationship, Drug; Humans; Injections, Intramuscular; Medroxyprogesterone; Neoplasms

1982
[Myelopoietic effect of medroxyprogesterone acetate at high parenteral doses in the cancer patient].
    Sangre, 1982, Volume: 27, Issue:5

    Topics: Antineoplastic Agents; Bone Marrow; Female; Hematopoiesis; Humans; Male; Medroxyprogesterone; Middle Aged; Neoplasms; Random Allocation

1982
Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects.
    American journal of veterinary research, 1981, Volume: 42, Issue:10

    Topics: Adenofibroma; Animals; Castration; Cat Diseases; Cats; Female; Hydrocortisone; Hypertrophy; Hysterectomy; Male; Mammary Glands, Animal; Medroxyprogesterone; Megestrol; Neoplasms; Neoplasms, Hormone-Dependent; Pregnancy; Progesterone; Promegestone; Receptors, Progesterone

1981
[Standards, Options and Recommendations (SOR) for the use of appetite stimulants in oncology. Work group. Federation of the French Cancer Centres (FNCLCC)].
    Bulletin du cancer, 2000, Volume: 87, Issue:4

    Topics: Adrenal Cortex Hormones; Appetite Stimulants; Cachexia; Humans; Medroxyprogesterone; Megestrol; Neoplasms; Progesterone Congeners; Review Literature as Topic

2000
Medroxyprogesterone and palliative care: new indication. No impact on quality of life.
    Prescrire international, 2001, Volume: 10, Issue:51

    Topics: Antineoplastic Agents, Hormonal; Appetite; Appetite Stimulants; Clinical Trials as Topic; Humans; Medroxyprogesterone; Neoplasms; Palliative Care; Quality of Life; Treatment Outcome; Weight Loss

2001
Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years.
    Fertility and sterility, 1979, Volume: 31, Issue:3

    Topics: Adenoma; Animals; Dogs; Dose-Response Relationship, Drug; Estradiol; Female; Growth Hormone; Hormones; Hydrocortisone; Hyperplasia; Insulin; Mammary Glands, Animal; Medroxyprogesterone; Neoplasms; Progesterone; Prolactin; Thyrotropin; Time Factors; Triiodothyronine

1979
Medroxyprogesterone acetate: an injectable contraceptive.
    Advances in planned parenthood, 1977, Volume: 12, Issue:1

    Topics: Animals; Female; Humans; Medroxyprogesterone; Menstruation; Neoplasms; Uterine Hemorrhage

1977
Medroxyprogesterone acetate lowers plasma corticotropin and cortisol but does not suppress anterior pituitary responsiveness to human corticotropin releasing factor.
    Cancer, 1990, Nov-01, Volume: 66, Issue:9

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; beta-Endorphin; Corticotropin-Releasing Hormone; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Pituitary Gland, Anterior; Pituitary-Adrenal System

1990
The role of pharmacokinetics in the clinical treatment of metastases.
    Advances in experimental medicine and biology, 1988, Volume: 233

    Topics: Antineoplastic Agents; Doxorubicin; Epirubicin; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms; Tamoxifen

1988
Medroxyprogesterone acetate bioavailability after high-dose intraperitoneal administration in advanced cancer.
    Cancer chemotherapy and pharmacology, 1985, Volume: 14, Issue:3

    Topics: Antineoplastic Agents; Biological Availability; Humans; Injections, Intraperitoneal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms

1985
The effect of large doses of medroxyprogesterone acetate (MPA) on urinary estrogen levels and serum levels of cortisol T4 LH and testosterone in patients with advanced cancer.
    Obstetrics and gynecology, 1974, Volume: 43, Issue:2

    Topics: Adrenocorticotropic Hormone; Adult; Aged; Breast Neoplasms; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Hydrocortisone; Injections, Intramuscular; Kidney Neoplasms; Luteinizing Hormone; Male; Medroxyprogesterone; Melanoma; Middle Aged; Neoplasms; Pituitary-Adrenal System; Testosterone; Thyroid Gland; Thyroxine

1974
Topical and systemic contraceptive agents.
    The Medical letter on drugs and therapeutics, 1974, Apr-26, Volume: 16, Issue:9

    Topics: Blood Pressure; Carbohydrate Metabolism; Contraception; Contraceptive Agents; Contraceptive Devices; Contraceptives, Oral; Contraceptives, Postcoital; Diethylstilbestrol; Female; Humans; Intrauterine Devices; Lipid Metabolism; Male; Medroxyprogesterone; Neoplasms; Pregnancy; Prostaglandins; Thromboembolism

1974
DNA repair inhibition: a new mechanism of action of steroids with possible implications for tumor therapy.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1974, Volume: 146, Issue:2

    Topics: Contraceptives, Oral; Diethylstilbestrol; Dihydrotestosterone; DNA; DNA Repair; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Lymphocytes; Medroxyprogesterone; Neoplasms; Norethindrone; Norethynodrel; Progesterone; Testosterone; Thymidine; Tritium

1974
Management of the climacteric and postmenopausal woman.
    The Medical clinics of North America, 1972, Volume: 56, Issue:3

    Topics: Aged; Anxiety; Climacteric; Coronary Disease; Depression; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasms; Osteoporosis; Ovary; Psychophysiologic Disorders; Vaginitis; Vasomotor System

1972
Some clinical aspects of problems associated with oestrus and with its control in the bitch.
    The Journal of small animal practice, 1971, Volume: 12, Issue:7

    Topics: Animals; Castration; Dog Diseases; Dogs; Estrus; Female; Mammary Glands, Animal; Medroxyprogesterone; Megestrol; Neoplasms; Pregnancy; Pseudopregnancy; Uterine Diseases

1971